CELZ Creative Medical Technology Holdings, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 7, 2026
$0,95
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,6252 haftanın en düşüğü
$6,2552 haftanın en yükseği
Piyasa Değeri (MRQ)
$6M
P/E (TTM)
-0.3
Hisse Başına Kâr (TTM)
$-3.66
Gelir (TTM)
$3.0K
rozetleriniz
52 Haftlık Aralık
$1–$6
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$20
P/E
-0.3
ROE
-78.0%
Net Kâr Marjı
-201355.4%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
CELZ Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.95
Piyasa Değeri (MRQ)
$6M
P/E (TTM)
-0.3
Hisse Başına Kâr (TTM)
$-3.66
Gelir (TTM)
$3.0K
ROE (TTM)
-78.0%
52 Haftlık Aralık
$1–$6
CELZ Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 12 Haziran 2023 | 1-for-10 | Ters |
| 10 Kasım 2021 | 1-for-500 | Ters |
| 03 Şubat 2020 | 1-for-150 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$6.0K2016-12-31 → 2025-12-31
Hisse Başına Kâr$-2.522020-12-31 → 2025-12-31
Net kar marjı-201355.4%2017-12-31 → 2020-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CELZ | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -0.35Y ort. ≈-0.6 | ≈-0.6 | · | · | |
| F/S (TTM) | 2048.0 | · | 1.8 | Aşırı değerli | |
| F/D (MRQ) | 0.7 | · | 0.8 | Aşırı değerli | |
| Fiyat / Maddi Defter Değeri (MRQ) | 0.75Y ort. ≈4.1 | ≈4.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CELZ | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 66.9% | · | · | · | |
| Faaliyet Kâr Marjı (TTM) | -208004.4% | · | · | · | |
| Vergi Öncesi Kar Marjı (TTM) | -201285.8% | · | · | · | |
| Net Kâr Marjı (TTM) | -201355.4% | · | · | · | |
| ROA (TTM) | -73.3% | · | -62.7% | Zayıf | |
| ROE (TTM) | -78.0% | · | -92.9% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CELZ | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 12.9 | · | 2.8 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | CELZ | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -45.5%5Y ort. ≈-31.8% | ≈-31.8% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -59.2%5Y ort. ≈-57.1% | ≈-57.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -48.4% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | CELZ | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$1.5K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-27.9%
Sonraki Rapor
Kas 05, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 6, 2026 | $-0.41 | $-0.40 | -3.1% |
| 31 Mart 2026 | May 7, 2026 | $-0.38 | $-0.40 | 4.5% |
| 31 Aralık 2025 | $-0.73 | $-0.38 | -93.4% | |
| 30 Eylül 2025 | $-0.48 | $-0.49 | 2.0% | |
| 30 Haziran 2025 | $-0.48 | $-0.64 | 25.3% | |
| 31 Mart 2025 | $-0.83 | $-0.53 | -56.5% | |
| 31 Aralık 2024 | $-1.12 | $-0.64 | -74.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | |
| Cost of Revenue | $2.2K | $4.4K | $3.6K | $28.5K | $47.9K | $50.6K | $45.5K | $70.4K | $8.0K | $0 | · | · | |
| Gross Profit | $3.8K | $6.6K | $5.4K | $60.1K | $39.8K | $113.9K | $120.0K | $54.0K | $-3.2K | $0 | · | · | |
| R&D Expense | $2M | $2M | $2M | $6M | $109.2K | $0 | $0 | $96.6K | $260.1K | $85.3K | · | · | |
| SG&A Expense | $4M | $3M | $4M | $4M | $3M | $1M | $1M | $1M | $898.5K | $665.0K | · | · | |
| Operating Expenses | $6M | $6M | $6M | $10M | $3M | $1M | $1M | $1M | $1M | $759.7K | $20.8K | $19.4K | |
| Operating Income | $-6M | $-6M | $-6M | $-10M | $-3M | $-1M | $-1M | $-1M | $-1M | $-759.7K | $-20.8K | $-19.4K | |
| Interest Expense | · | · | · | $0 | $4M | $1M | $2M | $1M | $377.6K | $6.4K | · | · | |
| Other Non-op | $147.8K | $250.4K | $333.6K | $100.3K | $22M | $-35M | $-7M | $-13M | $-1M | $-6.4K | · | · | |
| Pretax Income | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | $-766.1K | $-30.8K | $-28.0K | |
| EPS (Basic) | · | · | · | $-0.93 | $7.37 | $-62.69 | · | · | · | · | · | · | |
| EPS (Diluted) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 | $-62.69 | · | · | · | · | · | · | |
| Shares (Basic) | · | · | · | 10,932,035 | 2,605,057 | 579,461 | · | · | · | · | 18,113,750 | 18,113,750 | |
| Shares (Diluted) | 2,382,797 | 1,480,420 | 1,407,632 | 10,932,035 | 3,248,619 | · | · | · | · | · | · | · | |
| EBITDA | · | · | · | · | · | $-1M | $-1M | · | $-1M | $-766.1K | $-20.8K | $-19.4K |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $3M | $8M | $11M | $98.0K | $88.6K | $304.1K | $13.7K | $221.9K | $100 | $954 | |
| Receivables | · | · | · | $0 | $2.5K | $0 | $5.6K | $9.6K | $4.8K | $0 | · | · | |
| Inventory | $0 | $2.2K | $6.6K | $10.2K | $10.9K | $0 | $0 | · | · | · | · | · | |
| Prepaid Expense | $138.8K | $192.7K | $277.2K | $338.1K | $0 | · | · | · | · | · | · | · | |
| Current Assets | $7M | $6M | $10M | $19M | $11M | $98.0K | $94.2K | $313.7K | $18.5K | $221.9K | $49.6K | $954 | |
| Intangibles | $407.2K | $530.6K | $441.0K | $435.6K | $527.7K | $619.8K | $436.6K | $163.5K | $184.6K | $100.6K | $0 | · | |
| Other Non-current Assets | · | · | · | · | $3.3K | · | · | · | · | · | · | · | |
| Total Assets | $8M | $7M | $11M | $19M | $11M | $717.8K | $530.8K | $477.2K | $203.1K | $322.5K | $49.6K | $954 | |
| Accounts Payable | $270.7K | $273.5K | $317.3K | $3M | $761.9K | $350.9K | $320.8K | $331.8K | $237.6K | $66.4K | $0 | $10.2K | |
| Accrued Liabilities | $0 | $39.9K | $39.9K | $39.9K | $24.4K | $159.8K | $120.5K | $21.6K | $23.1K | $4.9K | $0 | · | |
| Short-term Debt | · | · | · | · | · | $0 | · | · | · | · | $0 | · | |
| Current Liabilities | $284.9K | $327.6K | $371.4K | $3M | $1M | $41M | $9M | $4M | $2M | $453.9K | $100 | $154.0K | |
| Total Liabilities | $284.9K | $327.6K | $371.4K | $3M | $1M | $41M | $9M | $4M | $2M | $480.3K | $100 | $154.0K | |
| Long-term Debt | · | · | · | · | · | · | · | · | $493.2K | · | · | · | |
| Common Stock | $3.1K | $1.7K | $1.4K | $1.4K | $6.3K | $1.5K | $22.5K | $6.0K | $114.8K | $105.0K | $32.0K | $18.1K | |
| Paid-in Capital | $78M | $71M | $70M | $70M | $54M | $22M | $17M | · | · | · | $154.2K | $154.2K | |
| Retained Earnings | $-71M | $-65M | $-59M | $-54M | $-44M | $-62M | $-26M | $-17M | $-3M | $-766.6K | $-500 | $-325.3K | |
| Treasury Stock | $10.0K | $0 | $271.0K | $0 | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $8M | $6M | $10M | $16M | $10M | $-40M | $-8M | $-4M | $-2M | $-157.8K | $49.5K | $-153.0K | |
| Liabilities + Equity | $8M | $7M | $11M | $19M | $11M | $717.8K | $530.8K | $477.2K | $203.1K | $322.5K | $49.6K | $954 | |
| Shares Outstanding | 3,696,668 | 1,748,428 | 1,373,626 | 1,407,624 | 6,338,864 | 1,537,074 | 22,489,046 | 6,018,075 | 114,799,226 | 105,013,750 | 32,010,000 | 18,113,750 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $56.0K | $56.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $3.5K | $36.6K | $36.6K | $68.7K | $595.4K | $170.3K | $0 | $1.9K | $144.2K | $2.6K | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Amort. of Intangibles | $123.3K | $110.5K | $94.6K | $92.1K | $92.1K | $66.8K | $26.9K | $21.1K | $16.0K | $9.4K | · | · | |
| Operating Cash Flow | $-6M | $-5M | $-8M | $-8M | $-2M | $-434.6K | $-1M | $-1M | $-889.6K | $-445.2K | $-14.6K | $-17.3K | |
| Investing Cash Flow | $-50.5K | $6M | $3M | $-10M | $0 | $-250.0K | $0 | · | $0 | $-10.0K | $0 | $0 | |
| Stock Issued | $7M | $2M | $0 | $15M | $15M | $0 | · | $0 | $100.0K | $500.0K | · | · | |
| Stock Repurchased | $10.0K | $175.0K | $271.0K | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $100.0K | $500.0K | · | · | |
| Financing Cash Flow | $7M | $1M | $-271.0K | $15M | $13M | $693.9K | $997.7K | $1M | $681.5K | $677.0K | $13.9K | $17.9K | |
| Net Change in Cash | $1M | $2M | · | · | · | $9.4K | $-215.4K | $290.4K | $-208.2K | $221.8K | $-738 | $580 | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 69.2% | 72.5% | · | -66.7% | · | · | · | |
| Operating Margin | · | · | · | · | · | -677.7% | -682.9% | · | -24537.6% | · | · | · | |
| Net Margin | · | · | · | · | · | -22082.2% | -5126.1% | · | -55398.1% | · | · | · | |
| Pretax Margin | · | · | · | · | · | -22082.2% | -5126.1% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -677.7% | -682.9% | · | -24537.6% | · | · | · | |
| ROA | · | · | · | · | · | -5818.7% | -1683.3% | · | -1011.7% | -411.7% | -5258.3% | -4218.7% | |
| ROE | · | · | · | · | · | 170.6% | 145.8% | · | 222.1% | 1414.8% | 33.5% | 20.2% | |
| ROIC | · | · | · | · | · | 2.8% | 14.0% | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.5 | 0.0 | 0.0 | |
| Quick Ratio | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.5 | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | -0.9 | -0.6 | · | -3.1 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.3 | 0.3 | · | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 58.8 | 21.8 | · | 2.0 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | $-0.05 | $-0.36 | · | $-0.02 | $-0.00 | $-0.01 | $-0.01 | |
| Cash / Share | · | · | · | · | · | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 | $-62.69 | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -45.5% | 22.2% | -89.8% | 0.96% | -46.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -59.2% | -50.0% | -62.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -48.4% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | |
| Net Income TTM | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | $-766.1K | $-30.8K | $-28.0K | |
| Market Cap | · | · | · | · | · | $106.83B | $5.06B | · | $1.16T | $40.17T | $149.44B | · | |
| P/E | -0.8 | -0.6 | -1.2 | -4.1 | 3.9 | -2.2 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | 649401.8 | 30574.2 | · | 242154617.3 | · | · | · | |
| P/B | · | · | · | · | · | -2683.9 | -626.9 | · | -519790.8 | -254563057.3 | -813031.5 | · | |
| P / Tangible Book | 1.0 | 0.7 | 0.6 | 3.5 | 14.5 | · | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | · | -245829.3 | -4171.2 | · | -1306558.8 | 90217593.0 | -10208938.2 | · | |
| Earnings Yield | -128.6% | -160.6% | -81.6% | -24.4% | 25.4% | -45.1% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $3.0K | $0 | $0 | $3.0K | $3.0K | $0 | $8.0K | $0 | $3.0K | $6.0K | $0 | $0 | $18.6K | $55.0K | |
| Cost of Revenue | $0 | $0 | $994 | $0 | $0 | $1.2K | $1.2K | $0 | $3.2K | $0 | $1.2K | $2.4K | $0 | $0 | $5.7K | $16.0K | |
| Gross Profit | $0 | $0 | $2.0K | $0 | $0 | $1.8K | $1.8K | $0 | $4.8K | $0 | $1.8K | $3.6K | $0 | $0 | $12.9K | $39.0K | |
| R&D Expense | $459.2K | $541.7K | $550.1K | $465.2K | $501.3K | $743.3K | $471.8K | $581.8K | $924.7K | $422.4K | $349.4K | $992.7K | $309.5K | $319.0K | $5M | $230.9K | |
| SG&A Expense | $1M | $888.6K | $1M | $776.8K | $731.5K | $888.4K | $1M | $498.6K | $676.1K | $671.5K | $1M | $531.0K | $859.5K | $771.0K | $899.6K | $805.5K | |
| Operating Expenses | $2M | $1M | $2M | $1M | $1M | $2M | $2M | $1M | $2M | $1M | $2M | $2M | $1M | $1M | $6M | $1M | |
| Operating Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-2M | $-1M | $-1M | $-6M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $50 | · | $0 | |
| Other Non-op | $50.9K | $55.4K | $58.1K | $37.1K | $30.2K | $22.4K | $31.7K | $69.5K | $67.6K | $81.6K | $93.3K | $89.2K | $89.9K | $61.1K | $62.2K | $38.1K | |
| Pretax Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-6M | $-982.3K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-6M | $-982.3K | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.07 | |
| EPS (Diluted) | $-0.41 | $-0.38 | $-2.39 | $-0.48 | $-0.48 | $-0.83 | $-2.58 | $-0.75 | $-1.11 | $0.73 | · | · | · | · | · | $-0.07 | |
| Shares (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 14,068,412 | |
| Shares (Diluted) | 3,701,668 | 3,701,668 | · | 2,580,532 | 2,580,532 | 1,980,735 | · | 1,392,284 | 1,405,208 | 1,421,439 | · | · | · | · | · | 14,068,412 | |
| EBITDA | $-2M | $-1M | · | $-1M | $-1M | $-2M | · | $-1M | $-2M | $-1M | · | $-2M | $-1M | $-1M | · | $-1M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | $5M | $4M | $10M | $8M | $17M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Inventory | $125.0K | $125.0K | $0 | $994 | $994 | $994 | $2.2K | $3.4K | $3.4K | $6.6K | $6.6K | $7.8K | $10.2K | $10.2K | $10.2K | $15.9K | |
| Prepaid Expense | $70.5K | $105.0K | $138.8K | $35.0K | $87.6K | $140.2K | $192.7K | $67.6K | $129.1K | $190.6K | $277.2K | $61.5K | $153.7K | $245.9K | $338.1K | · | |
| Current Assets | $9M | $6M | $7M | $5M | $7M | $8M | $6M | $6M | $8M | $9M | $10M | $12M | $14M | $15M | $19M | $22M | |
| Intangibles | $355.5K | $378.4K | $407.2K | $438.2K | $469.2K | $500.0K | $530.6K | $553.2K | $382.5K | $411.7K | $441.0K | $466.5K | $389.6K | $412.6K | $435.6K | $458.6K | |
| Total Assets | $9M | $6M | $8M | $6M | $7M | $8M | $7M | $7M | $8M | $10M | $11M | $13M | $14M | $15M | $19M | $22M | |
| Accounts Payable | $684.4K | $293.5K | $270.7K | $247.2K | $263.4K | $272.2K | $273.5K | $273.8K | $322.2K | $336.8K | $317.3K | $367.0K | $344.4K | $353.4K | $3M | $327.8K | |
| Accrued Liabilities | · | · | $0 | $0 | $0 | $0 | $39.9K | $42.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $54.9K | |
| Current Liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K | $327.6K | $330.9K | $376.3K | $391.0K | $371.4K | $421.2K | $398.5K | $407.5K | $3M | $397.0K | |
| Total Liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K | $327.6K | $330.9K | $376.3K | $391.0K | $371.4K | $421.2K | $398.5K | $407.5K | $3M | · | |
| Common Stock | $6.5K | $3.1K | $3.1K | $2.6K | $2.6K | $2.6K | $1.7K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $14.1K | $1.4K | $14.1K | |
| Paid-in Capital | $82M | $78M | $78M | $74M | $74M | $74M | $71M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | |
| Retained Earnings | $-74M | $-72M | $-71M | $-69M | $-67M | $-66M | $-65M | $-63M | $-62M | $-60M | $-59M | $-57M | $-56M | $-55M | $-54M | $-48M | |
| Treasury Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $0 | $445.9K | $420.5K | $353.7K | $271.0K | $191.8K | · | · | $0 | · | |
| Stockholders' Equity | $9M | $6M | $8M | $6M | $7M | $8M | $6M | $7M | $8M | $9M | $10M | $12M | $14M | $15M | $16M | $22M | |
| Liabilities + Equity | $9M | $6M | $8M | $6M | $7M | $8M | $7M | $7M | $8M | $10M | $11M | $13M | $14M | $15M | $19M | $22M | |
| Shares Outstanding | 6,492,008 | 3,696,668 | 3,696,668 | 2,580,532 | 2,580,532 | 2,580,532 | 1,748,428 | 1,329,876 | 1,338,126 | 1,354,626 | 1,373,626 | 1,391,126 | 1,431,126 | 14,076,238 | 1,407,624 | 14,076,238 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $46.0K | · | $0 | $0 | $46.0K | · | · | · | · | · | $0 | |
| Stock-based Comp | $0 | $0 | $0 | $0 | $0 | $3.5K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | |
| Amort. of Intangibles | $22.9K | $28.9K | $30.9K | $31.1K | $30.7K | $30.6K | $22.6K | $29.3K | $29.3K | $29.3K | $25.5K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | |
| Operating Cash Flow | $-1M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-985.6K | $-1M | $-896.9K | $-2M | $-1M | $-986.7K | $-4M | $-4M | $-873.3K | |
| Investing Cash Flow | $0 | $-175.0K | $-50.5K | $0 | $0 | $0 | $0 | $-200.0K | $0 | $7M | $933.9K | $2M | $-5M | $5M | $-5M | $-5M | |
| Stock Issued | $4M | $0 | · | · | $0 | $3M | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $10.0K | $0 | $25.4K | $66.7K | $82.8K | $79.2K | $191.8K | $0 | $0 | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-10.0K | · | · | · | $-82.8K | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $13.4K | $4M | $0 | $0 | $3M | $2M | $-25.4K | $-66.6K | $-82.8K | $-79.2K | $-191.8K | $0 | $0 | $0 | $12 | |
| Net Change in Cash | $3M | $-1M | · | · | $-1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 60.0% | · | · | 60.0% | · | · | 60.0% | · | · | · | 70.9% | |
| Operating Margin | · | · | · | · | · | -55349.3% | · | · | -20316.3% | · | · | -25719.8% | · | · | · | -1855.3% | |
| Net Margin | · | · | · | · | · | -54603.2% | · | · | -19471.6% | · | · | -24232.5% | · | · | · | -1786.1% | |
| Pretax Margin | · | · | · | · | · | -54603.2% | · | · | -19471.6% | · | · | -24232.5% | · | · | · | -1786.1% | |
| EBITDA Margin | · | · | · | · | · | -55349.3% | · | · | -20316.3% | · | · | -25719.8% | · | · | · | -1855.3% | |
| ROA | -18.4% | -19.0% | · | -19.4% | -16.3% | -18.2% | · | -10.7% | -14.1% | -8.4% | · | -8.3% | -5.9% | -8.4% | · | -7.7% | |
| ROE | -19.5% | -19.8% | · | -20.3% | -17.1% | -18.9% | · | -11.2% | -14.6% | -8.7% | · | -8.5% | -6.0% | -8.7% | · | -9.0% | |
| ROIC | -18.1% | -23.9% | · | -22.8% | -18.5% | -20.6% | · | · | -21.3% | -12.2% | · | -12.8% | -8.7% | -7.5% | · | -4.6% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.9 | 19.7 | · | 20.7 | 23.9 | 27.4 | · | 19.1 | 20.2 | 23.5 | · | 28.6 | 34.5 | 36.3 | · | 55.4 | |
| Quick Ratio | · | · | · | · | · | · | · | · | · | · | · | 10.7 | 10.0 | 23.4 | · | 42.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -22261.4 | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.5 | 0.0 | · | 0.2 | 0.0 | 0.0 | · | 2.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.33 | $1.65 | · | $2.17 | $2.65 | $3.12 | · | $4.93 | $5.69 | $6.81 | · | $8.69 | $9.59 | $1.05 | · | $1.57 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.36 | · | · | · | $-0.80 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | $3.24 | $2.79 | $0.68 | · | $1.21 | |
| EPS (TTM) | $-3.66 | $-3.73 | · | $-4.37 | $-4.64 | $-5.27 | · | · | · | · | · | $-4.02 | $-4.02 | $-4.02 | · | $-4.02 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.0K | $3.0K | · | $6.0K | $6.0K | $14.0K | · | $11.0K | $17.0K | $9.0K | · | $24.6K | $73.6K | $73.6K | · | $137.8K | |
| Net Income TTM | $-6M | $-6M | · | $-6M | $-6M | $-6M | · | $-5M | $-6M | $-5M | · | $-10M | $-9M | $-10M | · | $-8M | |
| Market Cap | $9M | $8M | · | $9M | $7M | $6M | · | $4M | $5M | $7M | · | $7M | $7M | $70M | · | $62M | |
| P/E | -0.4 | -0.6 | · | -0.8 | -0.6 | -0.4 | · | · | · | · | · | -1.2 | -1.2 | -1.2 | · | -1.1 | |
| P/S | 3137.8 | 2538.4 | · | 1432.2 | 1139.7 | 400.0 | · | 374.8 | 303.0 | 784.2 | · | 278.2 | 90.1 | 956.3 | · | 449.6 | |
| P/B | 1.1 | 1.2 | · | 1.5 | 1.0 | 0.7 | · | 0.6 | 0.7 | 0.8 | · | 0.6 | 0.5 | 4.7 | · | 2.8 | |
| P / Tangible Book | 1.1 | 1.3 | · | 1.7 | 1.1 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.5 | 4.9 | · | 2.9 | |
| P / Cash Flow | · | -5.8 | · | · | · | -3.5 | · | · | · | -7.9 | · | · | · | -18.3 | · | · | |
| Earnings Yield | -252.4% | -181.1% | · | -131.2% | -175.1% | -242.9% | · | · | · | · | · | -81.7% | -86.7% | -80.4% | · | -91.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K |
| Net Gelir | $-6M | $-5M | $-5M | $-10M | $19M |
| Seyreltilmiş Hisse Başı Kâr | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 17 dosya · $591K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
17
Tutulan Değer
$591K
Yeni pozisyonlar
6
Çıkan pozisyonlar
3
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (0 önceki Ç'ye göre) | 3 (-2 önceki Ç'ye göre) | 4 (+2 önceki Ç'ye göre) | 3 (+1 önceki Ç'ye göre) | +276K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Hudson Bay Capital Management LP | $195.997 | 135.170 | 33,14% | Hisse senetleri |
| Anson Funds Management LP | $153.046 | 105.549 | 25,88% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $60.900 | 42.000 | 10,30% | Hisse senetleri |
| VANGUARD GROUP INC | $50.701 | 25.868 | 8,57% | Hisse senetleri |
| XTX Topco Ltd | $38.511 | 26.559 | 6,51% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $37.419 | 25.799 | 6,33% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.508 | 20.350 | 4,99% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $8.001 | 5.518 | 1,35% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $7.037 | 4.853 | 1,19% | Hisse senetleri |
| Global Retirement Partners, LLC | $5.971 | 4.118 | 1,01% | Hisse senetleri |
| UBS Group AG | $2.989 | 2.061 | 0,51% | Hisse senetleri |
| MORGAN STANLEY | $745 | 514 | 0,13% | Hisse senetleri |
| HARBOUR INVESTMENTS, INC. | $325 | 224 | 0,05% | Hisse senetleri |
| Bogart Wealth, LLC | $145 | 100 | 0,02% | Hisse senetleri |
| BARCLAYS PLC | $78 | 54 | 0,01% | Hisse senetleri |
| SBI Securities Co., Ltd. | $62 | 43 | 0,01% | Hisse senetleri |
| Motiv8 Investments LLC | $0 | 1 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Creative Acquisition Corp., Timothy Warbington | 01 Ekim 2026 | 13,70% | İlk başvuru | Pasif yatırım | SEC |
| Timothy Warbington, Creative Medical Health, Inc. ×5 başvurular | 18 Ekim 2018 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 8 içeriden öğrenenler · 3 yöneticiler · 6 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Timothy Warbington | President & CEO | 28 Haziran 2023 P | 12.209 | 0 | 0 | $0 |
| Donald Dickerson | CFO & Sr. VP | 09 Şubat 2022 A | · | 0 | 0 | $0 |
| Steven L White | President | 18 Mayıs 2016 S | 0 | 0 | 0 | $0 |
| Michael H. Finger | Yönetim kurulu üyesi | 19 Şubat 2025 S | 351 | 0 | 0 | $0 |
| Thomas Ichim | Yönetim kurulu üyesi | 22 Temmuz 2021 S | 4.529.522 | 0 | 0 | $0 |
| Amit Nilkanth Patel | Yönetim kurulu üyesi | 15 Temmuz 2021 A | · | 0 | 0 | $0 |
| CREATIVE MEDICAL HEALTH INC. | 10% sahip | 08 Ocak 2021 J | 113.474.233 | 0 | 0 | $0 |
| Timothy Herbst | 10% sahip | 02 Aralık 2016 P | 11.346.667 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 20.350 SH | 19 Ağustos 2026 | Günlük |
CELZ Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
Medyan hedef
$20.00
+2013,3%
2 28,6%
Güçlü Al
4 57,1%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-09-30Ortalama hedef $20.00 +2013,3%
Düşük$20.00
Ortalama$20.00
Yüksek$20.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CELZ | · | -0.8 | -45.5% | · | · | · |
| BIAF | · | · | · | · | · | · |
| ACXP | $6M | -0.5 | · | · | -180.3% | · |
| SKYE | $25M | -0.5 | · | · | -175.6% | · |
| BOLT | $11M | -0.3 | 0.07% | -433.7% | -102.2% | · |
| LNAI | $513M | -2.7 | · | · | -586.4% | · |
| ALZN | $5M | -0.4 | · | · | -598.1% | · |
| XBIO | · | -1.4 | 19.0% | · | · | · |
| CDIO | · | · | · | · | · | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 7, 2026